Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$5.76 - $11.95 $158,400 - $328,625
-27,500 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$6.17 - $18.82 $15,425 - $47,050
-2,500 Reduced 8.33%
27,500 $307,000
Q2 2020

Aug 14, 2020

BUY
$1.73 - $6.76 $51,900 - $202,800
30,000 New
30,000 $188,000

Others Institutions Holding SRNE

About Sorrento Therapeutics, Inc.


  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Symmetry Peak Management LLC Portfolio

Follow Symmetry Peak Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Symmetry Peak Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Symmetry Peak Management LLC with notifications on news.